Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel DiseaseMarieke J. H. Coenen, H. Akol, Dirk J. de Jong et al.|Gastroenterology|2015Cited by 199
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated PatientsEelco C. Brand, Marleen Willems, Marjolein A. Y. Klaassen et al.|Gastroenterology|2021Cited by 57
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry StudyTessa Straatmijer, Joep Grootjans, Martine van Workum et al.|Clinical Gastroenterology and Hepatology|2022Cited by 51
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel DiseaseRemi Mahmoud, Bas Oldenburg, Edo Savelkoul et al.|Clinical Gastroenterology and Hepatology|2022Cited by 18
Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort StudyLoes H.C. Nissen, Julie M. Janssen, Lauranne Derikx et al.|Inflammatory Bowel Diseases|2018Cited by 14